DEVIT Bags ₹4.4 Cr IT Deal, Shares Tick Up 🚀

Big news just dropped for Dev Information Technology Limited (DEVIT)! The company, whose shares were trading at ₹121.41, up 0.5% at the time of the announcement, has secured a major IT order worth approximately ₹4.4 crore from Alivus Lifesciences Limited.

This significant domestic deal is a testament to DEVIT’s expanding capabilities in the IT services space. Let’s break down what this order entails:

First off, a substantial portion, around ₹3.60 crore, is for Microsoft Select Plus perpetual licenses. Here’s where DEVIT’s expertise truly shines: while the billing for these licenses will be handled by a Licensing Solution Partner, DEVIT played a crucial advisory role. They helped Alivus Lifesciences align their IT infrastructure with the most suitable Microsoft licensing model. This highlights DEVIT’s deep understanding of complex enterprise IT requirements and their ability to drive digital transformation initiatives for clients.

Secondly, DEVIT also bagged a direct order worth ₹80 lakh from Alivus Lifesciences. This part of the deal covers a suite of essential enterprise software solutions, including products from industry giants like Microsoft, Zoho, Adobe, and TeamViewer. This demonstrates DEVIT’s strength in delivering integrated, multi-product solutions tailored precisely to a client’s business needs.

The execution period for this order is set for approximately 1-2 years, indicating a sustained engagement. This win underscores DEVIT’s position as a key player in providing comprehensive IT solutions, from strategic advisory on licensing to direct implementation of diverse software platforms. It’s certainly a positive development for the company as it continues to expand its footprint in the digital transformation landscape. Keep an eye on how this new partnership unfolds! ✨

source: Corporate Announcement

Join our Telegram for instant updates!